Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
The Journal of Headache and Pain|March 13, 2016
Structured education can improve primary-care management of headache: the first empirical evidence, from a controlled interventional studyMark Braschinsky, Sulev Haldre, Mart Kals, et al.Scientific Reports|March 15, 2019
Analysis of repetitive element expression in the blood and skin of patients with Parkinson's disease identifies differential expression of satellite elementsKimberley J Billingsley, Freddy Lättekivi, Anu Planken, et al.BMC Health Services Research|August 10, 2022
Risk factors for development of personal protective equipment induced headache: e-survey of medical staff in Baltic statesMantas Jokubaitis, Reda Timofejavaitė, Mark Braschinsky, et al.Brain and Behavior|November 16, 2016
Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndromeJulius Juurmaa, Ricarda A L Menke, Pierre Vila, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 2, 2019
Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusersAndres Asser, Atsuko Hikima, Mari Raki, et al.Medicine International|February 27, 2024
Diagnosis of manganism and manganese neurotoxicity: A workshop reportDonald R Mattison, Franco Momoli, Cemil Alyanak, et al.Frontiers in Neurology|August 26, 2021
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers-Study Protocol for a Multicentre, Randomized Controlled TrialMarjan J Meinders, Giovanni Gentile, Anette E Schrag, et al.Brain Research|October 4, 2016
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganeseAndres Asser, Sulev Kõks, Anniina Snellman, et al.BMC Neurology|March 11, 2010
Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangementsMark Braschinsky, Riin Tamm, Christian Beetz, et al.European Journal of Neurology|July 6, 2022
European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapiesGünther Deuschl, Angelo Antonini, Joao Costa, et al.Pageof 12